Samila Nasrollahi
Papers
1
Total Citations
18
H-Index
1
About
Dr. Samila Nasrollahi is a pioneering researcher in cancer biology and drug screening technologies, whose work centers on developing innovative assays to study and combat cancer metastasis. Her major contribution lies in the creation of an aqueous biphasic system for cancer cell migration assays, a breakthrough that enables robust, high-throughput screening of anti-cancer compounds. This technology, detailed in her highly cited 2013 paper (18 citations), addresses a critical need in oncology: identifying therapeutics that inhibit tumor cell motility, a fundamental driver of metastatic progression. By overcoming the limitations of traditional migration assays, Dr. Nasrollahi’s work provides a powerful tool for accelerating the discovery of drugs that can prevent cancer spread. Her research has significant implications for translational medicine, offering a scalable platform to screen large compound libraries efficiently. This achievement underscores her impact on the field, bridging the gap between basic cancer biology and practical drug development. Dr. Nasrollahi’s innovative approach continues to inspire researchers seeking to improve patient outcomes through targeted anti-metastatic therapies.
Research Focus
Key Achievements
Top Papers
- 1